Nos actualités et évènements
Efficience des équipes et des organisations, la clé de croissance pour votre entreprise !
Efficience ou Efficacité : Serait-ce uniquement une question de sémantique ? L’Efficacité : Remplir le contrat, satisfaire le client, atteindre l’objectif. L’Efficacité ne préjuge en rien de l’ensemble des ressources mobilisées pour obtenir ce résultat. L’Efficience : Mesurer [...]
Pour aller plus loin …
- Au sommaire de BiotechFinances n°907 du lundi 13 07 2020 LA UNE OncoDNA s’offre IntegraGen pour 14,5 M€ ESSENTIEL : monde, coté, non coté DU LUNDI AU JEUDI A 19H...Rédaction
- 15 h Biotech Express Jeudi : OncoDNA, IntegraGen, Theranexus, Biogen, LeZoom19H La société belge OncoDNA va lancer une OPA amicale sur IntegraGen (ALINT) de 14,5M€. Le prix offert, soit 2,20€ par...Rédaction
- Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer Wednesday, April 15th 2020 at 10:45am UTC ONTRUZANT® is Samsung Bioepis’ first oncology biosimilar available in the United States INCHEON,...Rédaction
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019 Thursday, February 6th 2020 at 9:00pm UTC Webcast and Conference Call Today at 4:30 p.m. ET Positive results from part...Rédaction
- AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand Thursday, April 30th 2020 at 9:30pm UTC ALBANY, N.Y.–(BUSINESS WIRE)– AMRI today announced its ongoing commitment to do its part...Rédaction
- Assistance Publique – Hôpitaux de Paris (AP-HP) And Median Technologies Reach a Research Collaboration Agreement Involving The iBiopsy® Platform Monday, March 2nd 2020 at 4:45pm UTC The collaboration agreement initially covers two joint clinical studies on liver cancer, involving...Rédaction
- ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV Friday, March 20th 2020 at 1:00pm UTC Simultaneous approval of VOCABRIA (cabotegravir oral tablets), for short-term treatment in conjunction with...Rédaction
- PolarityTE to Report Fiscal Year 2019 Financial Results on March 12, 2020 Tuesday, March 3rd 2020 at 1:00pm UTC SALT LAKE CITY–(BUSINESS WIRE)– PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and...Rédaction
- Top Pharmaceutical Company Visionaries to Keynote Veeva Summit Online Thursday, May 21st 2020 at 11:03am UTC Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines...Rédaction
- With Second Mevion Proton System Installed at Siteman Cancer Center, Additional Cancer Patients Begin Treatment Wednesday, July 8th 2020 at 11:00am UTC LITTLETON, Mass.–(BUSINESS WIRE)– Mevion Medical Systems announced today that patient treatment has commenced...Rédaction